MY106120A - Peptide derivatives. - Google Patents
Peptide derivatives.Info
- Publication number
- MY106120A MY106120A MYPI89001655A MYPI19891655A MY106120A MY 106120 A MY106120 A MY 106120A MY PI89001655 A MYPI89001655 A MY PI89001655A MY PI19891655 A MYPI19891655 A MY PI19891655A MY 106120 A MY106120 A MY 106120A
- Authority
- MY
- Malaysia
- Prior art keywords
- somatostatin
- peptide derivatives
- detectable element
- amino group
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
SOMATOSTATIN PEPTIDES BEARING AT LEAST ONE CHELATING GROUP FOR A DETECTABLE ELEMENT, SAID CHELATING GROUP BEING LINKED TO AN AMINO GROUP OF SAID PEPTIDE, AND SAID AMINO GROUP HAVING NO SIGNIFICANT BINDING AFFINITY FOR SOMATOSTATIN RECEPTORS, IN FREE OR SALT FORM, ARE COMPLEXED WITH A DETECTABLE ELEMENT AND AS SUCH ARE USEFUL AS A PHARMACEUTICAL, E.G. A RADIOPHARMACEUTICAL FOR IN VIVO IMAGING OF SOMATOSTATIN RECEPTOR POSITIVE TUMORS OR FOR THERAPY.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888828364A GB8828364D0 (en) | 1988-12-05 | 1988-12-05 | Improvements in/relating to organic compounds |
GB898916115A GB8916115D0 (en) | 1989-07-13 | 1989-07-13 | Improvements in or relating to organic compounds |
GB898916761A GB8916761D0 (en) | 1989-07-21 | 1989-07-21 | Improvements in or relating to organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MY106120A true MY106120A (en) | 1995-03-31 |
Family
ID=27264222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI89001655A MY106120A (en) | 1988-12-05 | 1989-11-29 | Peptide derivatives. |
Country Status (24)
Country | Link |
---|---|
JP (2) | JP2726320B2 (en) |
KR (1) | KR0156541B1 (en) |
AT (1) | AT403476B (en) |
AU (1) | AU633859B2 (en) |
BE (1) | BE1002296A5 (en) |
CA (1) | CA2004532C (en) |
CH (1) | CH678329A5 (en) |
DE (1) | DE3991505B4 (en) |
DK (1) | DK175338B1 (en) |
ES (1) | ES2023533A6 (en) |
FI (1) | FI102540B1 (en) |
FR (1) | FR2639947B1 (en) |
GB (1) | GB2225579B (en) |
HK (1) | HK189995A (en) |
HU (2) | HUT53375A (en) |
IE (1) | IE62091B1 (en) |
IL (1) | IL92534A (en) |
LU (1) | LU87633A1 (en) |
MY (1) | MY106120A (en) |
NL (1) | NL194828C (en) |
PT (1) | PT92487B (en) |
SA (1) | SA96160495B1 (en) |
SE (1) | SE508799C2 (en) |
WO (1) | WO1990006949A2 (en) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU639371B2 (en) * | 1987-07-10 | 1993-07-22 | Novartis Ag | Method of treating breast cancer |
DE3845000C2 (en) * | 1987-07-10 | 1998-11-19 | Novartis Ag | Compsn. contg. somatostatin analogues for treating breast cancer |
GB9111199D0 (en) * | 1991-05-23 | 1991-07-17 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5985240A (en) * | 1989-08-09 | 1999-11-16 | Rhomed Incorporated | Peptide radiopharmaceutical applications |
US5460785A (en) * | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
US5443816A (en) * | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
US5700444A (en) * | 1992-02-20 | 1997-12-23 | Rhomed Incorporated | Chemotactic peptide pharmaceutical applications |
GB9004017D0 (en) * | 1990-02-22 | 1990-04-18 | Krenning Eric P | Improvements in or relating to organic compounds |
US5382654A (en) * | 1992-02-05 | 1995-01-17 | Mallinckrodt Medical, Inc. | Radiolabelled peptide compounds |
US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
US5443815A (en) * | 1991-11-27 | 1995-08-22 | Diatech, Inc. | Technetium-99m labeled peptides for imaging |
US7238340B1 (en) | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
DE69229436T2 (en) * | 1991-02-08 | 1999-11-25 | Biomeasure Inc | USE OF SOMATOSTATIN ANALOGS FOR TREATING MELANOMAS |
CA2102633A1 (en) * | 1991-06-03 | 1992-12-04 | Peter H. Cox | Radiolabelled somatostatin derivatives, their preparation and use |
CA2113995C (en) * | 1991-08-29 | 2003-04-22 | Edward A. Deutsch | Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
US5225180A (en) * | 1991-09-10 | 1993-07-06 | Diatech, Inc. | Technetium-99m labeled somatostatin-derived peptides for imaging |
US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
US5738838A (en) * | 1992-02-20 | 1998-04-14 | Rhomed Incorporated | IKVAV peptide radiopharmaceutical applications |
WO1993012819A1 (en) * | 1992-01-03 | 1993-07-08 | Rhomed Incorporated | Protein- and peptide-metal ion pharmaceutical applications |
US5556609A (en) * | 1992-02-20 | 1996-09-17 | Rhomed Incorporated | YIGSR peptide radiopharmaceutical applications |
EP0642357B1 (en) * | 1992-02-05 | 2001-07-25 | Mallinckrodt Inc. | Radiolabelled somatostatin |
US5371184A (en) * | 1992-02-05 | 1994-12-06 | Mallinckrodt Medical, Inc. | Radiolabelled peptide compounds |
US5643549A (en) * | 1992-02-20 | 1997-07-01 | Rhomed Incorporated | Leukostimulatory agent for in vivo leukocyte tagging |
AU3967593A (en) * | 1992-03-25 | 1993-10-21 | Mallinckrodt Medical, Inc. | Method of intraoperatively detecting and locating tumoral tissues |
US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
US6017512A (en) * | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
US5871711A (en) * | 1992-06-23 | 1999-02-16 | Diatide, Inc. | Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
FI940109A (en) * | 1993-01-12 | 1994-10-11 | Sandoz Ag | peptides |
US5650134A (en) * | 1993-01-12 | 1997-07-22 | Novartis Ag (Formerly Sandoz Ltd.) | Peptides |
WO1994017829A1 (en) * | 1993-02-02 | 1994-08-18 | Neorx Corporation | Directed biodistribution of small molecules |
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
US5932189A (en) * | 1994-07-29 | 1999-08-03 | Diatech, Inc. | Cyclic peptide somatostatin analogs |
DE69426673T2 (en) * | 1993-06-23 | 2001-09-20 | Diatide Inc | RADIO-MARKED SOMATOSTATIN DERIVATIVES FOR IMAGING AND THERAPEUTIC USE |
CA2190727C (en) * | 1994-05-19 | 2006-07-18 | Sudhakar Kasina | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
US6051206A (en) * | 1994-06-03 | 2000-04-18 | Diatide, Inc | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
GB9417873D0 (en) * | 1994-09-06 | 1994-10-26 | Sandoz Ltd | Organic compounds |
US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
US5830431A (en) * | 1995-06-07 | 1998-11-03 | Mallinckrodt Medical, Inc. | Radiolabeled peptide compositions for site-specific targeting |
GB9708265D0 (en) | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
FI965181A (en) * | 1996-12-20 | 1998-06-21 | Map Medical Technologies Oy | Polyalcohol peptide derivatives |
US6630570B1 (en) | 1999-04-09 | 2003-10-07 | Insitut für Diagnostikforschung GmbH | Short-chain peptide-dye conjugates as contrast media for optical diagnosis |
US7175953B2 (en) | 1999-04-09 | 2007-02-13 | Institute Fuer Diagnostik Forschung | Short-warp peptide-dye conjugate as contrast agent for optical diagnostic |
DE19917713A1 (en) * | 1999-04-09 | 2000-10-19 | Diagnostikforschung Inst | Short-chain peptide-dye conjugates as contrast agents for optical diagnostics |
US6685914B1 (en) | 1999-09-13 | 2004-02-03 | Bristol-Myers Squibb Pharma Company | Macrocyclic chelants for metallopharmaceuticals |
DE60231801D1 (en) * | 2001-04-23 | 2009-05-14 | Mallinckrodt Inc | TC AND RE-LABELED RADIOACTIVE GLYCOSYLATED OCTREOTIDE DERIVATIVES |
CN100475271C (en) | 2003-08-20 | 2009-04-08 | 加利福尼亚大学董事会 | Somatostatin analogs with inhibitory activity to growth hormone release |
KR101152729B1 (en) * | 2003-09-17 | 2012-06-15 | 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 | Mechanism-based targeted pancreatic beta cell imaging and therapy |
EP2067786A1 (en) | 2007-12-07 | 2009-06-10 | ITALFARMACO S.p.A. | Novel non selective analogs of somatostatin |
WO2014081655A1 (en) | 2012-11-21 | 2014-05-30 | Serene Oncology, Llc | Tin-1 17m comprising somatostatin receptor binding compounds |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1222691A (en) * | 1981-12-29 | 1987-06-09 | Wilhelmus T. Goedemans | Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments |
US4652519A (en) * | 1983-02-03 | 1987-03-24 | Yeda Research And Development Company Limited | Bifunctional chelating agents and process for their production |
US4707352A (en) * | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group |
DE3511206A1 (en) * | 1985-03-28 | 1986-10-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Polypeptide derivatives, their preparation and pharmaceutical products which contain these polypeptide derivatives |
HUT42101A (en) * | 1985-01-07 | 1987-06-29 | Sandoz Ag | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds |
DE3522638A1 (en) * | 1985-06-25 | 1987-01-08 | Diamalt Ag | NEW SOMATOSTATIN DERIVATIVES |
US4678667A (en) * | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
DK172629B1 (en) * | 1986-02-14 | 1999-03-22 | Nihon Mediphysics Co Ltd | Reactive high molecular weight compounds with at least one free amino group, high molecular weight compounds combined with a physiological |
US4732974A (en) * | 1986-03-05 | 1988-03-22 | Mallinckrodt, Inc. | Metal ion labeling of carrier molecules |
US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
NL194729C (en) * | 1986-10-13 | 2003-01-07 | Novartis Ag | Process for the preparation of peptide alcohols via solid phase. |
CH679045A5 (en) * | 1987-06-29 | 1991-12-13 | Sandoz Ag | |
US5073541A (en) * | 1987-11-18 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Treatment of small cell lung cancer with somatostatin analogs |
FR2638968B1 (en) * | 1988-11-11 | 1994-10-07 | Sandoz Sa | NEW THERAPEUTIC USE OF SOMATOSTATIN AND ITS ANALOGS AND DERIVATIVES |
-
1989
- 1989-11-29 MY MYPI89001655A patent/MY106120A/en unknown
- 1989-11-30 CH CH2578/90A patent/CH678329A5/de not_active IP Right Cessation
- 1989-11-30 DE DE3991505A patent/DE3991505B4/en not_active Expired - Lifetime
- 1989-11-30 WO PCT/EP1989/001448 patent/WO1990006949A2/en active Application Filing
- 1989-11-30 AT AT0901789A patent/AT403476B/en active
- 1989-12-01 GB GB8927255A patent/GB2225579B/en not_active Expired - Lifetime
- 1989-12-04 KR KR1019890018033A patent/KR0156541B1/en not_active IP Right Cessation
- 1989-12-04 PT PT92487A patent/PT92487B/en active IP Right Grant
- 1989-12-04 FR FR8915993A patent/FR2639947B1/en not_active Expired - Lifetime
- 1989-12-04 HU HU896359A patent/HUT53375A/en unknown
- 1989-12-04 FI FI895809A patent/FI102540B1/en active IP Right Grant
- 1989-12-04 CA CA002004532A patent/CA2004532C/en not_active Expired - Lifetime
- 1989-12-04 NL NL8902981A patent/NL194828C/en not_active IP Right Cessation
- 1989-12-04 SE SE8904087A patent/SE508799C2/en unknown
- 1989-12-04 IL IL9253489A patent/IL92534A/en not_active IP Right Cessation
- 1989-12-04 IE IE386689A patent/IE62091B1/en not_active IP Right Cessation
- 1989-12-04 JP JP1315124A patent/JP2726320B2/en not_active Expired - Lifetime
- 1989-12-04 AU AU45871/89A patent/AU633859B2/en not_active Expired
- 1989-12-05 ES ES8904151A patent/ES2023533A6/en not_active Expired - Lifetime
- 1989-12-05 BE BE8901294A patent/BE1002296A5/en not_active IP Right Cessation
- 1989-12-05 DK DK198906126A patent/DK175338B1/en not_active IP Right Cessation
- 1989-12-05 LU LU87633A patent/LU87633A1/en unknown
-
1995
- 1995-06-15 HU HU95P/P00214P patent/HU211468A9/en unknown
- 1995-12-21 HK HK189995A patent/HK189995A/en not_active IP Right Cessation
-
1996
- 1996-01-01 SA SA96160495A patent/SA96160495B1/en unknown
-
1997
- 1997-08-04 JP JP20891597A patent/JP3686503B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY106120A (en) | Peptide derivatives. | |
IL95118A0 (en) | Polypeptide derivatives,their preparation and pharmaceutical compositions containing them | |
US5225180A (en) | Technetium-99m labeled somatostatin-derived peptides for imaging | |
García-Garayoa et al. | In vitro and in vivo evaluation of new radiolabeled neurotensin (8–13) analogues with high affinity for NT1 receptors | |
Einspahr et al. | Crystal structure studies of calcium complexes and implications for biological systems | |
GR3026658T3 (en) | Hydrazino-type radionuclide chelators having an n 3?s configuration | |
ZA954547B (en) | Technetium-99m labeled peptides for imaging | |
DE69326335T2 (en) | Technetium-99M labeled peptides for imaging | |
ES8705919A1 (en) | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor. | |
EP0877760A4 (en) | ||
JPH08503924A (en) | Radiolabeled somatostatin-derived peptides for imaging and therapeutic applications | |
EP0966297A4 (en) | Methods for regulating gastrointestinal motility | |
EP0975374A4 (en) | Radiometal-binding peptide analogues | |
ATE302211T1 (en) | RADIOMETALL BINDING ANALOGUE FROM LHRH | |
EP1270585A4 (en) | Peptide derivative | |
SE8804164A (en) | ||
AU7528894A (en) | Hydrazino-type n2s2 chelators | |
DE69434384D1 (en) | METALKOMPLEXBILDNER | |
BG103872A (en) | Glycoconjugates of 20(s)-camptotecin | |
CA2069638A1 (en) | Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands | |
GR1002475B (en) | Method for preparing peptidic derivatives | |
EP0264953A3 (en) | Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use | |
AU3602695A (en) | Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications | |
FI943306A (en) | A method of preparing a ligand complexed with a pharmaceutically useful radionuclide | |
WATANABE et al. | Amino-Acid Sequence of LC-1 Light Chain of Squid Mantle Muscle Myosin |